Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

(2010) Vanessa Deschoolmeester et al.   BMC IMMUNOLOGY

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer

(2010) Won-Suk Lee et al.   CANCER

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data

(2010) Cecilia Guastadisegni et al.   EUROPEAN JOURNAL OF CANCER

Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer

(2010) J. A. D. Simpson et al.   GUT

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

(2010) Katsuhiko Nosho et al.   JOURNAL OF PATHOLOGY

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

(2009) J. A. Sanchez et al.   BRITISH JOURNAL OF SURGERY

Microsatellite instability and survival in rectal cancer

(2009) Wade S. Samowitz et al.   CANCER CAUSES & CONTROL

One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case–referent study

(2009) Bethany Van Guelpen et al.   CANCER CAUSES & CONTROL

Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

(2009) S. Ogino et al.   CLINICAL CANCER RESEARCH

Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

(2009) Frank A. Sinicrope et al.   GASTROENTEROLOGY

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

(2009) Monica M. Bertagnolli et al.   JOURNAL OF CLINICAL ONCOLOGY

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

(2009) Luigi Laghi et al.   LANCET ONCOLOGY

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

(2009) Jung Ho Kim et al.   VIRCHOWS ARCHIV

Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases

(2008) L. Barault et al.   CANCER RESEARCH

Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy

(2008) M. Morris et al.   CLINICAL CANCER RESEARCH

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Classification and Correlates in Colorectal Cancer

(2007) Shuji Ogino et al.   JOURNAL OF MOLECULAR DIAGNOSTICS